NCT02669862View on ClinicalTrials.gov

A Study of A-101 Solution in Subjects With Common Warts.

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

December 21, 2015

Primary Completion Date

September 16, 2016

Study Completion Date

September 16, 2016

Conditions
Common Warts
Interventions
DRUG

A-101 Solution 40

DRUG

A-101 Solution 45

DRUG

Vehicle Solution

Trial Locations (1)

19087

Aclaris Therapeutics, Inc., Wayne

Sponsors
All Listed Sponsors
lead

Aclaris Therapeutics, Inc.

INDUSTRY

NCT02669862 - A Study of A-101 Solution in Subjects With Common Warts. | Biotech Hunter | Biotech Hunter